Evolus, Inc. (LON:0K16)
14.58
+0.43 (3.00%)
At close: Jan 31, 2025
Evolus Employees
Evolus had 332 employees as of December 31, 2024. The number of employees increased by 59 or 21.61% compared to the previous year.
Employees
332
Change (1Y)
59
Growth (1Y)
21.61%
Revenue / Employee
514.90K GBP
Profits / Employee
-114.85K GBP
Market Cap
365.37M
Employees Chart
Employees History
Date | Employees | Change | Growth |
---|---|---|---|
Dec 31, 2024 | 332 | 59 | 21.61% |
Dec 31, 2023 | 273 | 58 | 26.98% |
Dec 31, 2022 | 215 | 48 | 28.74% |
Dec 31, 2021 | 167 | 48 | 40.34% |
Dec 31, 2020 | 119 | -116 | -49.36% |
Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
Company Name | Employees |
---|---|
AstraZeneca | 94,300 |
GSK plc | 68,629 |
Haleon | 24,561 |
Smith & Nephew | 17,349 |
ConvaTec Group | 10,489 |
Hikma Pharmaceuticals | 9,500 |
HUTCHMED (China) | 1,811 |
Oxford Nanopore Technologies | 1,382 |
Evolus News
- 7 days ago - Evolus Announces Positive Data From Pivotal Trial for Evolysse™ Sculpt Injectable Hyaluronic Acid Gel Product at 2025 Cosmetic Bootcamp - Business Wire
- 12 days ago - Evolus Announces Submission of Premarket Approval Application to the U.S. Food and Drug Administration for Evolysse™ Sculpt Injectable Hyaluronic Acid Gel Product - Business Wire
- 14 days ago - Insider Buying: Brady Stewart Acquires 30,000 Shares of Evolus Inc (EOLS) - GuruFocus
- 24 days ago - Evolus Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - Business Wire
- 26 days ago - Evolus plunges after Q2 miss, guidance cut; Needham downgrades - Seeking Alpha
- 26 days ago - Evolus (EOLS) Q2 Revenue Rises 4% - The Motley Fool
- 27 days ago - Evolus outlines $700M 2028 revenue target and cost realignment amid market softness - Seeking Alpha
- 27 days ago - Evolus, Inc. (EOLS) Q2 2025 Earnings Call Transcript - Seeking Alpha